Evidence map›Paper›PMID 41602516›Full record

ReviewCureus2026

Gut Microbiota and Colorectal Cancer: Is Microbial Dysbiosis in Carcinogenesis an Emerging Risk Factor?

Olurotimi J Badero, Emmanuel S Meribole, Olutomiwa Omokore, Ibrahim O Quadri, Perelade Kingdom, Ogbuiyi-Chima C Ifeanyichukwu, Samuel O Ogunnoiki, Precious M Samuel-Ogunnoiki, Olaitan Adeyoola, Bamikole Osibowale and 4 more

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Olurotimi J BaderoInterventional Cardiology, Iwosan Lagoon Hospital, Lagos, NGA.
Emmanuel S MeriboleMedicine and Surgery, Babcock University Teaching Hospital, Ilishan-Remo, NGA.
Olutomiwa OmokoreInternal Medicine, Babcock University Teaching Hospital, Ilishan-Remo, NGA.
Ibrahim O QuadriSurgery, Babcock University, Ilishan-remo, NGA.
Perelade KingdomSurgery, Benjamin S. Carson (Snr) School of Medicine, Ilishan-Remo, NGA.
Ogbuiyi-Chima C IfeanyichukwuMedicine and Surgery, Babcock University Teaching Hospital, Ilishan-remo, NGA.
Samuel O OgunnoikiInternal Medicine, Benjamin S. Carson (Snr) School of Medicine, Ilishan-Remo, NGA.
Precious M Samuel-OgunnoikiInternal Medicine, Benjamin S. Carson College of Health and Medical Sciences, Ilishan-Remo, NGA.
Olaitan AdeyoolaMedicine, Babcock University, Ilishan-Remo, NGA.
Bamikole OsibowaleCardiology, Carribean Tristate Heart Institute, Port of Spain, TTO.
Nkechi Chima-OgbuiyiNursing, Herzing University, Milwaukee, USA.
Mariam O BuariMedicine, Babcock University Teaching Hospital, Ilishan-Remo, NGA.
Juliet UmehSurgery, Igbinedion University, Okada, NGA.
Adetola AdeyemiMedicine and Surgery, Lagos University Teaching Hospital, Ikeja, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiome has emerged as a critical factor in colorectal cancer (CRC) development, offering significant potential for early diagnosis and novel approaches. Current screening methods like colonoscopy and faecal immunochemical tests (FIT), while effective, face limitations in accessibility and patient compliance.  Recent research has identified distinct microbial signatures associated with CRC, including elevated levels of

Indexed as

colorectal cancerdiagnostic biomarkersgut-microbiotamicrobial dysbiosispersonalised medicine

Identifiers

PMID41602516
PMCPMC12834471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.